Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Arcturus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ARCT.
You can purchase shares of Arcturus Therapeutics (NASDAQ:ARCT) through any online brokerage.
Other companies in Arcturus Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Altimmune (NASDAQ:ALT), aTyr Pharma (NASDAQ:ATYR), Monte Rosa Therapeutics (NASDAQ:GLUE) and Olema Pharmaceuticals (NASDAQ:OLMA).
Arcturus Therapeutics has a consensus price target of $47.00.
The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $9.5195 last updated April 11, 2025 at 6:33 PM EDT.
There are no upcoming dividends for Arcturus Therapeutics.
Arcturus Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Arcturus Therapeutics.
Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.